Viewing Study NCT03064035

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:30 PM
Ignite Modification Date: 2026-02-11 @ 3:26 AM
Study NCT ID: NCT03064035
Status: COMPLETED
Last Update Posted: 2023-09-14
First Post: 2017-02-16
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal
Sponsor: HealthPartners Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Bleeding on Long-Term Anticoagulation Therapy View
None Hemorrhage View
None Significant Bleeding in Patients With a Coagulopathy (Prolonged Thrombin Time) View
None Urgent Reversal of Vitamin K Antagonist (VKA) Anticoagulation View
Keywords: